VENUS REMEDIES
|
VENUS REMEDIES Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹62 Cr | ₹45 Cr | ₹38 Cr | ₹36 Cr | ₹25 Cr |
| Adjustment | ₹15 Cr | ₹20 Cr | ₹23 Cr | ₹26 Cr | ₹22 Cr |
| Changes In working Capital | ₹25 Cr | ₹-12 Cr | ₹-25 Cr | ₹-22 Cr | ₹61 Cr |
| Cash Flow after changes in Working Capital | ₹101 Cr | ₹53 Cr | ₹37 Cr | ₹41 Cr | ₹108 Cr |
| Cash Flow from Operating Activities | ₹86 Cr | ₹37 Cr | ₹37 Cr | ₹41 Cr | ₹132 Cr |
| Cash Flow from Investing Activities | ₹-76 Cr | ₹-7.21 Cr | ₹-51 Cr | ₹-17 Cr | ₹56 Cr |
| Cash Flow from Financing Activities | ₹-1.02 Cr | ₹-1.08 Cr | ₹-0.57 Cr | ₹-9.48 Cr | ₹-162 Cr |
| Net Cash Inflow / Outflow | ₹9.18 Cr | ₹29 Cr | ₹-15 Cr | ₹15 Cr | ₹26 Cr |
| Opening Cash & Cash Equivalents | ₹49 Cr | ₹21 Cr | ₹43 Cr | ₹29 Cr | ₹1.94 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | ₹-0.61 Cr | ₹-1.25 Cr | ₹-7.27 Cr | ₹-0.52 Cr | ₹0.85 Cr |
| Closing Cash & Cash Equivalent | ₹58 Cr | ₹49 Cr | ₹21 Cr | ₹43 Cr | ₹29 Cr |
Compare Cashflow Statement of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,408.5 Cr | 1.2% | 17.3% | 228.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -1.4% | -6.2% | -1.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,939.0 Cr | -0.1% | 2.3% | 9.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,109.0 Cr | -1.8% | -4.9% | 28.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,578.0 Cr | -0.4% | -6% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,761.1 Cr | 0.4% | -2.6% | -17.6% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 1.2% |
17.3% |
228.2% |
| SENSEX | 0.5% |
3.2% |
2.3% |
You may also like the below Video Courses